Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, today announced the appointment of Dr. David Pyott, former Chairman and Chief Executive Officer of Allergan, to Pliant’s Board of Directors.

https://www.globenewswire.com/news-release/2021/01/12/2157021/0/en/Pliant-Therapeutics-Announces-Appointment-of-David-Pyott-to-Board-of-Directors.html